Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 20/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 14/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14645825 | 0.88 | HDAC4 (0.65) | HDAC4HDAC6HDAC1 | |
| SCHEMBL22531083 | 0.87 | HDAC4 (0.70) | HDAC4HDAC6HDAC1 | |
| SCHEMBL30931870 | 0.87 | HDAC4 (0.70) | HDAC4HDAC6HDAC1 | |
| SCHEMBL29625964 | 0.87 | HDAC4 (0.64) | HDAC4HDAC6HDAC1 | |
| SCHEMBL29241997 | 0.84 | HDAC4 (0.60) | HDAC4HDAC6HDAC1 | |
| SCHEMBL21038624 | 0.82 | HDAC4 (0.76) | HDAC4HDAC6HDAC1 | |
| SCHEMBL20838193 | 0.81 | HDAC4 (0.68) | HDAC4HDAC6HDAC1 | |
| SCHEMBL20838025 | 0.81 | HDAC4 (0.68) | HDAC4HDAC6HDAC1 | |
| SCHEMBL22530593 | 0.81 | HDAC4 (0.64) | HDAC4HDAC6HDAC1 | |
| SCHEMBL21380548 | 0.81 | HDAC4 (0.69) | HDAC4HDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108779109-B | Microbicidal oxadiazole derivatives | 先正达参股股份有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-11192867-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-12-07 | — | — | US | disclosed |
| CN-108368099-B | Microbicidal oxadiazole derivatives | 先正达参股股份有限公司 | 2021-11-12 | — | — | CN | disclosed |
| US-11154060-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-26 | — | — | US | disclosed |
| US-11154060-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-26 | — | — | US | disclosed |
| US-10959432-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-03-30 | — | — | US | disclosed |
| US-10959432-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-03-30 | — | — | US | disclosed |
| EP-3464251-B1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2021-03-03 | — | — | EP | disclosed |
| US-20200267986-A1 | Microbiocidal Oxadiazole Derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2020-08-27 | — | — | US | disclosed |
| US-20200267986-A1 | Microbiocidal Oxadiazole Derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2020-08-27 | — | — | US | disclosed |
| EP-3390399-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | Syngenta Participations AG (CH) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017207757-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-12-07 | — | — | WO | disclosed |
| WO-2017198852-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-11-23 | — | — | WO | disclosed |
| WO-2017198852-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-11-23 | — | — | WO | disclosed |
| WO-2017174158-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-10-12 | — | — | WO | disclosed |
| WO-2017174158-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-10-12 | — | — | WO | disclosed |
| WO-2017157962-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-21 | — | — | WO | disclosed |
| WO-2017157962-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-09-21 | — | — | WO | disclosed |
| WO-2017102006-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017102006-A1 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192867-B2 | Microbiocidal oxadiazole derivatives | PRF1, NOX1, ARG2 | HDAC4 1469/4885HDAC6 611/4885HDAC1 584/4885 |
| US-10959432-B2 | Microbiocidal oxadiazole derivatives | PRF1, NOX1, ARG1 | HDAC4 1487/4885HDAC6 678/4885HDAC1 597/4885 |
| US-11154060-B2 | Microbiocidal oxadiazole derivatives | MPO, MSR1, NOX3 | HDAC4 1387/4885HDAC6 564/4885HDAC1 435/4885 |
| US-20200267986-A1 | Microbiocidal Oxadiazole Derivatives | PRF1, NOX1, ARG1 | HDAC4 1487/4885HDAC6 678/4885HDAC1 597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.